Literature DB >> 19104364

Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard.

Nancy K Lowe1, Jeremy L Neal, Nancy A Ryan-Wenger.   

Abstract

OBJECTIVE: To estimate the accuracy of the clinical diagnosis of the three most common causes of acute vulvovaginal symptoms (bacterial vaginosis, candidiasis vaginitis, and trichomoniasis vaginalis) using a traditional, standardized clinical diagnostic protocol compared with a DNA probe laboratory standard.
METHODS: This prospective clinical comparative study had a sample of 535 active-duty United States military women presenting with vulvovaginal symptoms. Clinical diagnoses were made by research staff using a standardized protocol of history, physical examination including pelvic examination, determination of vaginal pH, vaginal fluid amines test, and wet-prep microscopy. Vaginal fluid samples were obtained for DNA analysis. The research clinicians were blinded to the DNA results.
RESULTS: The participants described a presenting symptom of abnormal discharge (50%), itching/irritation (33%), malodor (10%), burning (4%), or others such as vulvar pain and vaginal discomfort. According to laboratory standard, there were 225 cases (42%) of bacterial vaginosis, 76 cases (14%) of candidiasis vaginitis, 8 cases (1.5%) of trichomoniasis vaginalis, 87 cases of mixed infections (16%), and 139 negative cases (26%). For each single infection, the clinical diagnosis had a sensitivity and specificity of 80.8% and 70.0% for bacterial vaginosis, 83.8% and 84.8% for candidiasis vaginitis, and 84.6% and 99.6% for trichomoniasis vaginalis when compared with the DNA probe standard.
CONCLUSION: Compared with a DNA probe standard, clinical diagnosis is 81-85% sensitive and 70-99% specific for bacterial vaginosis, Candida vaginitis, and trichomoniasis. Even under research conditions that provided clinicians with sufficient time and materials to conduct a thorough and standardized clinical evaluation, the diagnosis and, therefore, subsequent treatment of these common vaginal problems remains difficult. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19104364      PMCID: PMC2745984          DOI: 10.1097/AOG.0b013e3181909f63

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

1.  How do clinicians manage vaginal complaints? An Internet survey.

Authors:  Matthew R Anderson; Alison Karasz
Journal:  MedGenMed       Date:  2005-06-21

2.  Affirm VP III in the detection and identification of Candida species in vaginitis.

Authors:  G Petrikkos; K Makrilakis; S Pappas
Journal:  Int J Gynaecol Obstet       Date:  2006-12-21       Impact factor: 3.561

Review 3.  Clinical practice. Acute vulvovaginitis.

Authors:  Linda O Eckert
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

4.  Evaluation of clinical methods for diagnosing bacterial vaginosis.

Authors:  Robert E Gutman; Jeffrey F Peipert; Sherry Weitzen; Jeffrey Blume
Journal:  Obstet Gynecol       Date:  2005-03       Impact factor: 7.661

5.  A clinical test of women's self-diagnosis of genitourinary infections.

Authors:  N K Lowe; N A Ryan-Wenger
Journal:  Clin Nurs Res       Date:  2000-05       Impact factor: 2.075

6.  Use of DNA hybridization test for diagnosing bacterial vaginosis in women with symptoms suggestive of infection.

Authors:  Horu Gazi; Kenan Degerli; Ozgur Kurt; Asli Teker; Yildiz Uyar; Husnu Caglar; Semra Kurutepe; Suheyla Surucuoglu
Journal:  APMIS       Date:  2006-11       Impact factor: 3.205

Review 7.  A growing concern: inability to diagnose vulvovaginal infections correctly.

Authors:  William J Ledger; Gilles R G Monif
Journal:  Obstet Gynecol       Date:  2004-04       Impact factor: 7.661

Review 8.  Expansion of altered vaginal flora states in vaginitis to include a spectrum of microflora.

Authors:  R Stuart Fowler
Journal:  J Reprod Med       Date:  2007-02       Impact factor: 0.142

9.  Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis.

Authors:  A M Briselden; S L Hillier
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

Review 10.  Evaluation of vaginal complaints.

Authors:  Matthew R Anderson; Kathleen Klink; Andreas Cohrssen
Journal:  JAMA       Date:  2004-03-17       Impact factor: 56.272

View more
  13 in total

Review 1.  Syndromic Diagnosis in Evaluation of Women with Symptoms of Vaginitis.

Authors:  Theophilus Ogochukwu Nwankwo; Uzochukwu Uzoma Aniebue; Uchenna Anthony Umeh
Journal:  Curr Infect Dis Rep       Date:  2017-01       Impact factor: 3.725

2.  Diagnosing Vaginal Infections: It's Time to Join the 21st Century.

Authors:  Barbara Van Der Pol
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

3.  The Role of PCR in the Diagnosis of Candida Vulvovaginitis-a New Gold Standard?

Authors:  J D Sobel; Robert A Akins
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

4.  Mixed vaginitis-more than coinfection and with therapeutic implications.

Authors:  Jack D Sobel; Chitra Subramanian; Betsy Foxman; Marilyn Fairfax; Scott E Gygax
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

5.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

Review 6.  Trichomoniasis: evaluation to execution.

Authors:  Djana F Harp; Indrajit Chowdhury
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-03-25       Impact factor: 2.435

7.  Rapid differential diagnosis of vaginal infections using gold nanoparticles coated with specific antibodies.

Authors:  Hossein Hashemi; Jaleh Varshosaz; Hossein Fazeli; Seyedeh Maryam Sharafi; Hossein Mirhendi; Mostafa Chadeganipour; HosseinAli Yousefi; Kourosh Manoochehri; Zahra Aliyari Chermahini; Lobat Jafarzadeh; Nafiseh Dehghanisamani; Parvin Dehghan; Hossein Yousofi Darani
Journal:  Med Microbiol Immunol       Date:  2019-06-10       Impact factor: 3.402

Review 8.  The Human Microbiome during Bacterial Vaginosis.

Authors:  Andrew B Onderdonk; Mary L Delaney; Raina N Fichorova
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

9.  What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.

Authors:  Jill Huppert; Elizabeth Hesse; Charlotte A Gaydos
Journal:  Point Care       Date:  2010-03-01

10.  Accuracy of vaginal symptom self-diagnosis algorithms for deployed military women.

Authors:  Nancy A Ryan-Wenger; Jeremy L Neal; Ashley S Jones; Nancy K Lowe
Journal:  Nurs Res       Date:  2010 Jan-Feb       Impact factor: 2.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.